Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012896 · ClinicalTrials.gov registry record · NA
Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT00012896: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00012896 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 320 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012896, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
Cancer pain is a pervasive problem for the person with cancer. Despite advances in knowledge, effective cancer management is infrequently achieved. While this problem is multi-factorial, the patient may have attitudinal barriers to effective pain management that can be ameliorated with novel interventions.
Interventions
- BEHAVIORAL Telephone Care + Educational (AV Materials)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Est. Completion | 2004-09 |
| Phase | NA |
What the finished NCT00012896 record still lists
NCT00012896 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Telephone Care + Educational (AV Materials) is the first listed.
NCT00012896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00012896 about?
NCT00012896 is a clinical study titled "Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines". Cancer pain is a pervasive problem for the person with cancer. Despite advances in knowledge, effective cancer management is infrequently achieved. While this problem is multi-factorial, the patient may have attitudinal barriers to effective pain management that can be ameliorated with novel interve...
What is the current status of trial NCT00012896?
This trial is currently completed. It is a NA study. The enrollment target is 320 participants. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00012896?
The interventions under investigation include: Telephone Care + Educational (AV Materials) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00012896?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00012896's enrollment target sits among peer trials
320 315th of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow